Cargando…
Optimizing Antimicrobial and Host-Directed Therapies to Improve Clinical Outcomes of Childhood Tuberculous Meningitis( )
Autores principales: | Gafar, Fajri, Marais, Ben J, Nataprawira, Heda M, Alffenaar, Jan Willem C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410716/ https://www.ncbi.nlm.nih.gov/pubmed/34910810 http://dx.doi.org/10.1093/cid/ciab1036 |
Ejemplares similares
-
Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia
por: Nataprawira, Heda M., et al.
Publicado: (2022) -
Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis
por: Ruslami, Rovina, et al.
Publicado: (2022) -
Host Directed Therapies for Tuberculous Meningitis
por: Davis, Angharad G., et al.
Publicado: (2021) -
Additional considerations for "checklists to guide the supportive and critical care of tuberculous meningitis"
por: Behl, Anuradha, et al.
Publicado: (2020) -
Meningitis in Childhood: Purulent and Tuberculous Infections
por: Corner, Beryl D.
Publicado: (1955)